These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11711298)

  • 1. QSAR of the inhibition of angiogenesis by TNP-470 and ovalicin analogues: another example of an allosteric interaction.
    Mekapati SB; Hansch C
    Bioorg Med Chem; 2001 Dec; 9(12):3225-30. PubMed ID: 11711298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells.
    Turk BE; Griffith EC; Wolf S; Biemann K; Chang YH; Liu JO
    Chem Biol; 1999 Nov; 6(11):823-33. PubMed ID: 10574784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin.
    Griffith EC; Su Z; Turk BE; Chen S; Chang YH; Wu Z; Biemann K; Liu JO
    Chem Biol; 1997 Jun; 4(6):461-71. PubMed ID: 9224570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic analogues of TNP-470 and ovalicin reveal a common molecular basis for inhibition of angiogenesis and immunosuppression.
    Turk BE; Su Z; Liu JO
    Bioorg Med Chem; 1998 Aug; 6(8):1163-9. PubMed ID: 9784858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis.
    Zhou G; Tsai CW; Liu JO
    J Med Chem; 2003 Jul; 46(16):3452-4. PubMed ID: 12877582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methionine AminoPeptidase Type-2 Inhibitors Targeting Angiogenesis.
    Ehlers T; Furness S; Robinson TP; Zhong HA; Goldsmith D; Aribser J; Bowen JP
    Curr Top Med Chem; 2016; 16(13):1478-88. PubMed ID: 26369821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single amino acid residue defines the difference in ovalicin sensitivity between type I and II methionine aminopeptidases.
    Brdlik CM; Crews CM
    J Biol Chem; 2004 Mar; 279(10):9475-80. PubMed ID: 14676204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis inhibitors specific for methionine aminopeptidase 2 as drugs for malaria and leishmaniasis.
    Zhang P; Nicholson DE; Bujnicki JM; Su X; Brendle JJ; Ferdig M; Kyle DE; Milhous WK; Chiang PK
    J Biomed Sci; 2002; 9(1):34-40. PubMed ID: 11810023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2.
    Griffith EC; Su Z; Niwayama S; Ramsay CA; Chang YH; Liu JO
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15183-8. PubMed ID: 9860943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2.
    Sin N; Meng L; Wang MQ; Wen JJ; Bornmann WG; Crews CM
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6099-103. PubMed ID: 9177176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of TNP-470-induced modifications to cell functions in HUVEC and cancer cells.
    Farinelle S; Malonne H; Chaboteaux C; Decaestecker C; Dedecker R; Gras T; Darro F; Fontaine J; Atassi G; Kiss R
    J Pharmacol Toxicol Methods; 2000; 43(1):15-24. PubMed ID: 11091126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homology modeling and calculation of the cobalt cluster charges of the Encephazlitozoon cuniculi methionine aminopeptidase, a potential target for drug design.
    Bontems F; le Floch P; Duffieux F; Biderre C; Peyret P; Lallemand JY
    Biophys Chem; 2003 Aug; 105(1):29-43. PubMed ID: 12932577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1.
    Zhang Y; Griffith EC; Sage J; Jacks T; Liu JO
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6427-32. PubMed ID: 10841547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinosarcoma-induced endothelial cells tube formation through KDR/Flk-1 is blocked by TNP-470.
    Miura S; Emoto M; Matsuo Y; Kawarabayashi T; Saku K
    Cancer Lett; 2004 Jan; 203(1):45-50. PubMed ID: 14670616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivo.
    Lu J; Chong CR; Hu X; Liu JO
    J Med Chem; 2006 Sep; 49(19):5645-8. PubMed ID: 16970390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and gemcitabine in a human bladder cancer KoTCC-1 model.
    Muramaki M; Miyake H; Hara I; Kawabata G; Kamidono S
    J Urol; 2004 Oct; 172(4 Pt 1):1485-9. PubMed ID: 15371876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of novel fumagillin analogues as angiogenesis inhibitors.
    Pyun HJ; Fardis M; Tario J; Yang CY; Ruckman J; Henninger D; Jin H; Kim CU
    Bioorg Med Chem Lett; 2004 Jan; 14(1):91-4. PubMed ID: 14684305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis inhibitor TNP-470 suppresses growth of peritoneal disseminating foci of human colon cancer line Lovo.
    Fan YF; Huang ZH
    World J Gastroenterol; 2002 Oct; 8(5):853-6. PubMed ID: 12378629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of angiogenesis inhibitor TNP-470 on the growth, blood flow, and microvessel density in xenografts of human uterine carcinosarcoma in nude mice.
    Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
    Gynecol Oncol; 2003 Apr; 89(1):88-94. PubMed ID: 12694659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice.
    Beecken WD; Fernandez A; Panigrahy D; Achilles EG; Kisker O; Flynn E; Joussen AM; Folkman J; Shing Y
    Urology; 2000 Sep; 56(3):521-6. PubMed ID: 10962337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.